Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Generative AI in Life Sciences Market Size & Share, By Technology (Novel molecule generation, Protein sequence design, Synthetic gene design, Single-cell RNA sequencing, Data augmentation for model training), Application (Drug Discovery, Biotechnology, Medical Diagnosis, Clinical Trials, Precision and Personalized Medicine, Patient Monitoring) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 6873| Published Date: Jan-2025| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Generative AI in Life Sciences Market size is forecast to grow from USD 232.1 million to USD 1.51 billion between 2025 and 2034, marking a CAGR of more than 20.6%. The expected industry revenue in 2025 is USD 275.13 million.

Base Year Value (2024)
USD 232.1 million
CAGR (2025-2034)
20.6%
Forecast Year Value (2034)
USD 1.51 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
SNAPSHOT

Generative AI in Life Sciences Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
41% Market Share in 2024
North America The Generative AI in Life Sciences market is experiencing significant growth in North America, driven primarily by technological advancements and increased investment in healthcare innovation. The United States is the leading country in the adoption of generative AI, with numerous research institutions and biotech companies leveraging AI for drug discovery, personalized medicine, and clinical trials. The presence of major tech companies and a robust venture capital environment further accelerate the development of AI solutions in healthcare. Canada is also witnessing growth, particularly in research initiatives and partnerships between academic institutions and industry players, focusing on improving patient outcomes and optimizing healthcare services. Asia Pacific In the Asia Pacific region, the generative AI in life sciences market is rapidly evolving, with China, Japan, and South Korea at the forefront. China is heavily investing in AI research and development, aiming to integrate AI technology into its healthcare system. Chinese companies are exploring generative AI for drug development and genomics, making significant strides in enhancing efficiency and reducing costs. Japan's emphasis on robotics and AI in healthcare has fostered the adoption of generative AI for medical imaging and diagnostic purposes. South Korea is also emerging as a key player, with its government supporting AI initiatives in life sciences, leading to collaborations between tech firms and pharmaceutical companies. Europe The Generative AI in Life Sciences market in Europe is characterized by robust regulatory frameworks and a strong emphasis on data privacy. The United Kingdom is a leader in biotechnology innovation, with several initiatives aimed at utilizing AI for drug discovery and optimizing healthcare delivery systems. Germany is also investing in AI, focusing on the integration of generative AI in clinical research and treatment personalization. France is promoting digital health solutions and has a growing number of startups focusing on AI-driven approaches to disease management and treatment efficacy. Overall, Europe is fostering a collaborative environment for AI in life sciences, with active participation from universities, research institutions, and healthcare organizations.
SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Go beyond the chart, access full insights & data tables

Request Free Sample Report
By Technology The Generative AI in Life Sciences Market is seeing significant advancement in the technology segment. Novel molecule generation is at the forefront, enabling researchers to design and discover new compounds with targeted properties, revolutionizing drug discovery processes. Protein sequence design follows closely, facilitating the creation of proteins tailored for specific functionalities, thus advancing therapeutic and diagnostic applications. Synthetic gene design is also gaining traction, allowing for the customization of genetic constructs, which enhances synthetic biology workflows. Single-cell RNA sequencing technology is essential for understanding cellular diversity and gene expression on an individual cell level, providing insights for precision medicine. Additionally, data augmentation for model training is crucial, as it enhances the robustness and accuracy of predictive models, contributing to better outcomes in various life sciences applications. By Application In the application segment, Drug Discovery emerges as a primary area benefiting from Generative AI, significantly speeding up the identification of viable drug candidates while reducing costs. Biotechnology applications are also prominent, leveraging AI innovations to enhance bioprocessing and the development of biologics. Medical Diagnosis utilizes generative models to improve the accuracy and efficiency of diagnostic tools, allowing for quicker detection of diseases. Clinical Trials are witnessing a transformation through AI, which helps optimize trial design and patient selection, ultimately shortening the trial timeline. Precision and Personalized Medicine is becoming more achievable with AI-driven insights, leading to more targeted treatment plans based on individual genetic and phenotypic profiles. Finally, Patient Monitoring applications benefit from AI's predictive capabilities, enabling proactive health management and timely interventions for chronic conditions.
Competitive Landscape

Competitive Landscape and Market Positioning

The competitive landscape in the Generative AI in Life Sciences Market is rapidly evolving, with a diverse range of players leveraging advanced AI technologies to revolutionize drug discovery, personalized medicine, and clinical research. Companies are increasingly investing in research and development to enhance their Generative AI capabilities, while also forming strategic partnerships and collaborations to expand their technological reach and access to proprietary datasets. The integration of AI in life sciences not only accelerates the drug development process but also improves accuracy in predicting outcomes, thereby attracting significant attention from both established corporations and startups. As regulatory frameworks begin to adapt to these new technologies, the competitive dynamics will likely intensify, leading to further innovation and market disruption. Top Market Players 1. IBM 2. Google Health 3. NVIDIA 4. Microsoft 5. AstraZeneca 6. Roche 7. Merck 8. Insilico Medicine 9. BenevolentAI 10. Certara
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Generative AI in Life Sciences Market — Custom Segments

Segment Sub-Segment
No segment data available.

Generative AI in Life Sciences Market — Custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Smart Technologies Research Team at Fundamental Business Insights, a dedicated research group specializing in emerging digital technologies and intelligent connected systems. Our analysts continuously monitor advancements in artificial intelligence, Internet of Things (IoT), cloud computing, edge computing, cybersecurity, automation, digital transformation strategies, and evolving enterprise adoption trends to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with technology providers, software vendors, system integrators, enterprise users, and industry experts, along with company annual reports, investor presentations, regulatory publications, technology standards, industry associations, technical white papers, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Smart Technologies Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Internet of Things (IoT) Artificial Intelligence & Machine Learning Smart Home Technologies Smart Cities & Infrastructure Connected Devices & Systems Cloud & Edge Computing Digital Twins & Simulation Cybersecurity & Data Protection Automation & Intelligent Systems Connected Buildings & Smart Facilities

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →